Advertisement
Screener

Coherus Oncology, Inc. (CHRS) Patents: Active

Coherus Oncology, Inc. Active Patents

26 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2022-11-15: Application 17998818; Invention SYSTEMS AND METHODS FOR PRODUCING STERILE INJECTION DEVICES; Applicant COHERUS BIOSCIENCES, INC.; Status Patented Case.
  • 2022-05-06: Application 17738927; Invention ANTI-IL-27 ANTIBODIES AND USES THEREOF; Applicant Surface Oncology, LLC; Status Patented Case.
  • 2022-04-06: Application 17714942; Invention ANTI-IL-27 ANTIBODIES AND USES THEREOF; Applicant Surface Oncology, LLC; Status Patented Case.
  • 2021-11-19: Application 17531380; Invention Anti-CD112R Compositions and Methods; Applicant Surface Oncology, LLC; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2022-11-1517998818SYSTEMS AND METHODS FOR PRODUCING STERILE INJECTION DEVICESCOHERUS BIOSCIENCES, INC.Patented Case2023-09-1211752225US20230201387A1
Wendy SHIEU
Gerald LLORACH
United States
United States
ACKUN, JACOB K
2022-05-0617738927ANTI-IL-27 ANTIBODIES AND USES THEREOFSurface Oncology, LLCPatented Case2026-03-1712577299US20220389089A1
Alison O'NEILL
Lauren HARSHMAN
Jonathan HILL
Jou-Ku CHUNG
Kerry WHITE
Robert ROSS
Benjamin LEE
United States
United States
United States
United States
United States
United States
United States
LUCAS, ZACHARIAH
2022-04-0617714942ANTI-IL-27 ANTIBODIES AND USES THEREOFSurface Oncology, LLCPatented Case2026-05-1912630624US20230042258A1
Jonathan HILL
Scott CHAPPEL
Michael GLADSTONE
Bianka PRINZ
Andrew LAKE
Christine MILLER
Kerry WHITE
Jing HUA
Pamela M. HOLLAND
Matthew RAUSCH
Devapregasan MOODLEY
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
MCCOLLUM, ANDREA K
2021-11-1917531380Anti-CD112R Compositions and MethodsSurface Oncology, LLCPatented Case2024-12-1012162941US20220162317A1
Bianka PRINZ
Nadthakarn BOLAND
Kevin SCHUTZ
John BUKOWSKI
Jennifer SYMONDS
James MOHAN
Marisella Panduro SICHEVA
United States
United States
United States
United States
United States
United States
United States
NATARAJAN, MEERA
2021-06-1717350299METHOD OF FILLING A CONTAINER WITH NO HEADSPACECoherus Biosciences, Inc.Patented Case2023-02-1411576971US20220040300A1
John Ogez
Jun Liu
Wenchang Ji
Patrick Daniel Begley
Isaias Prado
Mark Manning
United States
United States
United States
United States
United States
United States
RUSHING-TUCKER, CHINYERE J
2021-06-1117413269ANTI-IL-27 ANTIBODIES AND USES THEREOFSurface Oncology, LLCPatented Case2025-07-1512358978US20220259299A1
Jonathan HILL
Scott CHAPPEL
Michael GLADSTONE
Bianka PRINZ
Andrew LAKE
Christine MILLER
Kerry WHITE
Jing HUA
Pamela M. HOLLAND
Matthew RAUSCH
Devapregasan MOODLEY
Gege TAN
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
SWARTWOUT, BRIANNA KENDALL
2019-09-2516497523PPARy AGONIST FOR TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSYCoherus Biosciences, Inc.Patented Case2022-02-2211253508US20210283121A1
Barbara Finck
David E. Weinstein
Sarita K. Jain
United States
United States
United States
WARD, PAUL V
2019-09-1016566847STABLE AQUEOUS FORMULATIONS OF AFLIBERCEPTCoherus BioSciences Inc.Patented Case2022-08-3011426446US20200246423A1
Jun Liu
Mark Manning
Sekhar R. Kanapuram
United States
United States
United States
KIM, YUNSOO
2019-09-0916564642METHODS FOR MAKING RECOMBINANT PROTEINSCoherus Biosciences, Inc.Patented Case2022-07-2611396540
Elzbieta Wiktoria Puchacz
United States
HAMUD, FOZIA M
2019-03-0816297387Stable Aqueous Formulations of AfliberceptCoherus BioSciences Inc.Patented Case2023-06-0611667702US20190276528A1
Jun Liu
Mark Manning
United States
United States
KIM, YUNSOO
2018-06-2916023161STABLE AQUEOUS FORMULATIONS OF ADALIMUMABCoherus Biosciences, Inc.Patented Case2020-10-1310799585US20180311351A1
Mark Manning
Robert W. Payne
United States
United States
KIM, YUNSOO
2018-06-2916023152STABLE AQUEOUS FORMULATIONS OF ADALIMUMABCoherus Biosciences, Inc.Patented Case2020-09-1510772960US20180311350A1
Mark Manning
Robert W. Payne
United States
United States
KIM, YUNSOO
2018-06-2916023046STABLE AQUEOUS FORMULATIONS OF ADALIMUMABCoherus Biosciences, Inc.Patented Case2020-09-1510772959US20180311349A1
Mark Manning
Robert W. Payne
United States
United States
KIM, YUNSOO
2018-01-0915866154STABLE AQUEOUS FORMULATIONS OF ADALIMUMABCoherus Biosciences, Inc.Patented Case2019-02-0510195275US20180140701A1
Mark Manning
Robert W. Payne
United States
United States
KIM, YUNSOO
2017-10-3115799851Stable Aqueous Formulations of AdalimumabCoherus Biosciences, Inc.Patented Case2018-12-1810155039US20180055930A1
Mark Manning
Robert W. Payne
United States
United States
KIM, YUNSOO
2017-10-1015729295METHODS OF MANUFACTURING STABLE AQUEOUS FORMULATIONS OF ADALIMUMABCoherus Biosciences, Inc.Patented Case2019-05-1410286072US20180028654A1
Mark Manning
Robert W. Payne
United States
United States
KIM, YUNSOO
2017-10-1015729243Syringe Containing Stable Aqueous Formulations of AdalimumabCoherus Biosciences, Inc.Patented Case2019-05-1410286071US20180028653A1
Mark Manning
Robert W. Payne
United States
United States
KIM, YUNSOO
2017-10-0515726215Stable Aqueous Formulations of AdalimumabCoherus Biosciences, Inc.Patented Case2018-12-2510159733US20180043019A1
Mark Manning
Robert W. Payne
United States
United States
KIM, YUNSOO
2017-10-0515726195Stable Aqueous Formulations of AdalimumabCoherus Biosciences, Inc.Patented Case2019-02-1910207000US20180055929A1
Mark Manning
Robert W. Payne
United States
United States
KIM, YUNSOO
2017-10-0515726165Stable Aqueous Formulations of AdalimumabCoherus Biosciences, Inc.Patented Case2018-12-2510159732US20180043018A1
Mark Manning
Robert W. Payne
United States
United States
KIM, YUNSOO
2017-08-1515677857STABLE AQUEOUS FORMULATIONS OF ADALIMUMABCoherus Biosciences, Inc.Patented Case2020-09-2910786566US20180021433A1
Mark Manning
Robert W. Payne
United States
United States
KIM, YUNSOO
2017-07-1815653228Stable Aqueous Formulations of AdalimumabCoherus Biosciences, Inc.Patented Case2020-09-2210780163US20170312361A1
Mark Manning
Robert W. Payne
United States
United States
KIM, YUNSOO
2016-10-2815337845STABLE ADALIMUMAB COMPOSITIONS AND METHODS OF THEIR USECoherus Biosciences, Inc.Patented Case2023-02-2111583584
Jun Liu
Mark Manning
Isaias Prado
United States
United States
United States
KIM, YUNSOO
2016-10-2815337519HIGH CONCENTRATION FORMULATIONS OF ADALIMUMABCoherus Biosciences, Inc.Patented Case2022-01-2511229702
Mark Manning
Ryan Erik Holcomb
United States
United States
KIM, YUNSOO
2016-05-1615155925Stable Aqueous Formulations of AdalimumabCoherus Biosciences, Inc.Patented Case2017-07-189707293US20160256546A1
Mark Manning
Robert W. Payne
United States
United States
KIM, YUNSOO
2015-09-0414845440METHODS FOR MAKING RECOMBINANT PROTEINSCoherus Biosciences, Inc.Patented Case2019-10-0810435464
Elzbieta Wiktoria Puchacz
United States
HAMUD, FOZIA M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Alpha Cognition Inc. (ACOG)$0.185B-6.77
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Alector, Inc. (ALEC)United States$0.213B-1.90
ANAVEX LIFE SCIENCES CORP. (AVXL)United States$0.218B-18.37